vs
Side-by-side financial comparison of Edwards Lifesciences (EW) and Hershey Company (The) (HSY). Click either name above to swap in a different company.
Hershey Company (The) is the larger business by last-quarter revenue ($3.1B vs $1.6B, roughly 1.9× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 14.0%, a 9.1% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 10.6%). Over the past eight quarters, Hershey Company (The)'s revenue compounded faster (22.3% CAGR vs 9.7%).
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.
The Hershey Company, often called just Hershey or Hershey's, is an American multinational confectionery company headquartered in Hershey, Pennsylvania, which is also home to Hersheypark and Hershey's Chocolate World. The Hershey Company is one of the largest chocolate manufacturers in the world; it also manufactures baked products, such as cookies and cakes, and sells beverages like milkshakes, as well as other products. The Hershey Company was founded by Milton S. Hershey in 1894 as the Hers...
EW vs HSY — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $3.1B |
| Net Profit | $380.7M | $435.1M |
| Gross Margin | 78.0% | 39.4% |
| Operating Margin | 1.8% | 20.6% |
| Net Margin | 23.1% | 14.0% |
| Revenue YoY | 16.7% | 10.6% |
| Net Profit YoY | 6.8% | — |
| EPS (diluted) | $0.66 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | $3.1B | ||
| Q4 25 | $1.6B | $3.1B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.4B | $2.8B | ||
| Q4 24 | $1.4B | $2.9B | ||
| Q3 24 | $1.4B | $3.0B | ||
| Q2 24 | $1.4B | $2.1B |
| Q1 26 | $380.7M | $435.1M | ||
| Q4 25 | $91.2M | $320.0M | ||
| Q3 25 | $291.1M | $276.3M | ||
| Q2 25 | $333.2M | $62.7M | ||
| Q1 25 | $358.0M | $224.2M | ||
| Q4 24 | $385.6M | $796.6M | ||
| Q3 24 | $3.1B | $446.3M | ||
| Q2 24 | $366.3M | $180.9M |
| Q1 26 | 78.0% | 39.4% | ||
| Q4 25 | 78.1% | 37.0% | ||
| Q3 25 | 77.8% | 32.6% | ||
| Q2 25 | 77.5% | 30.5% | ||
| Q1 25 | 78.7% | 33.7% | ||
| Q4 24 | 78.9% | 54.0% | ||
| Q3 24 | 80.6% | 41.3% | ||
| Q2 24 | 79.9% | 40.2% |
| Q1 26 | 1.8% | 20.6% | ||
| Q4 25 | 9.6% | 14.4% | ||
| Q3 25 | 19.8% | 13.7% | ||
| Q2 25 | 26.8% | 7.4% | ||
| Q1 25 | 27.9% | 13.2% | ||
| Q4 24 | 22.6% | 32.5% | ||
| Q3 24 | 25.9% | 20.5% | ||
| Q2 24 | 26.8% | 13.9% |
| Q1 26 | 23.1% | 14.0% | ||
| Q4 25 | 5.8% | 10.4% | ||
| Q3 25 | 18.7% | 8.7% | ||
| Q2 25 | 21.7% | 2.4% | ||
| Q1 25 | 25.3% | 8.0% | ||
| Q4 24 | 27.8% | 27.6% | ||
| Q3 24 | 226.7% | 14.9% | ||
| Q2 24 | 26.7% | 8.7% |
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | — | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.56 | — | ||
| Q1 25 | $0.61 | — | ||
| Q4 24 | $0.65 | — | ||
| Q3 24 | $5.13 | — | ||
| Q2 24 | $0.61 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $877.0M |
| Total DebtLower is stronger | — | $4.9B |
| Stockholders' EquityBook value | — | $4.7B |
| Total Assets | — | $13.8B |
| Debt / EquityLower = less leverage | — | 1.03× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $877.0M | ||
| Q4 25 | $4.2B | — | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.0B | — | ||
| Q3 24 | $4.4B | — | ||
| Q2 24 | $2.0B | — |
| Q1 26 | — | $4.9B | ||
| Q4 25 | — | $4.7B | ||
| Q3 25 | — | $4.7B | ||
| Q2 25 | — | $5.2B | ||
| Q1 25 | — | $5.2B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | — | $3.5B |
| Q1 26 | — | $4.7B | ||
| Q4 25 | $10.3B | $4.6B | ||
| Q3 25 | $10.2B | $4.6B | ||
| Q2 25 | $10.5B | $4.5B | ||
| Q1 25 | $10.1B | $4.7B | ||
| Q4 24 | $10.0B | $4.7B | ||
| Q3 24 | $9.5B | $4.2B | ||
| Q2 24 | $7.4B | $4.0B |
| Q1 26 | — | $13.8B | ||
| Q4 25 | $13.7B | $13.7B | ||
| Q3 25 | $13.3B | $13.6B | ||
| Q2 25 | $13.5B | $13.6B | ||
| Q1 25 | $13.0B | $14.0B | ||
| Q4 24 | $13.1B | $12.9B | ||
| Q3 24 | $13.0B | $12.6B | ||
| Q2 24 | $10.1B | $12.4B |
| Q1 26 | — | 1.03× | ||
| Q4 25 | — | 1.01× | ||
| Q3 25 | — | 1.02× | ||
| Q2 25 | — | 1.15× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.87× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
